SCHEMBL6964162

SCHEMBL6964162

Cc1cc(-c2cc(O)cc(=O)o2)ccc1OCc1cccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
PRKDC P78527 3/20 0.44
HCAR2 Q8TDS4 1/20 0.42
P2RY12 Q9H244 1/20 0.42
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42
NOS2 P35228 1/20 0.42
ALDH1A1 P00352 3/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
PIK3CD O00329 2/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PIK3CG P48736 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6964221 0.79 HTR1A (0.41) PDE3BPDE3APRKDCP2RY12NOS3
SCHEMBL7406156 0.73 CYP1A2 (0.47) PRKDCALDH1A1CYP1A2CYP3A4CYP2C9
SCHEMBL19019868 0.73 PDE3B (0.66) PDE3BPDE3APRKDCHCAR2P2RY12
SCHEMBL6963969 0.72 BRD4 (0.48) ALDH1A1MRGPRX4KMT2ASMN1; SMN2LRRK2
SCHEMBL30354972 0.71 CYP19A1 (0.55) PRKDCNOS3NOS1NOS2ALDH1A1
SCHEMBL13642585 0.71 SMN1; SMN2 (0.59) NOS3NOS1NOS2ALDH1A1KDM4E
SCHEMBL7914979 0.71 ALDH1A1 (0.48) PRKDCNOS3NOS1NOS2ALDH1A1
SCHEMBL8540378 0.71 ACHE (0.48) PRKDCACHEMAOB
SCHEMBL12111187 0.70 LMNA (0.46) ALDH1A1MRGPRX4KMT2ASMN1; SMN2LRRK2
SCHEMBL13814708 0.69 ALDH1A1 (0.47) NOS3NOS1NOS2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed